| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8227490 | BAUSCH | Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis |
Sep, 2017
(6 years ago) | |
| US7981909 | BAUSCH | Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis |
Sep, 2017
(6 years ago) | |
Loprox is owned by Bausch.
Loprox contains Ciclopirox.
Loprox has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Loprox are:
- US8227490
- US7981909
Loprox was authorised for market use on 28 February, 2003.
Loprox is available in shampoo;topical dosage forms.
Loprox can be used as treatment of seborrheic dermatitis, treatment of seborrheic dermatitis of the scalp.
The generics of Loprox are possible to be released after 16 September, 2017.
Drugs and Companies using CICLOPIROX ingredient
Market Authorisation Date: 28 February, 2003
Treatment: Treatment of seborrheic dermatitis; Treatment of seborrheic dermatitis of the scalp
Dosage: SHAMPOO;TOPICAL
More Information on Dosage
LOPROX family patents
